BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 33951440)

  • 21. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.
    Wahdan-Alaswad RS; Bane KL; Song K; Shola DT; Garcia JA; Danielpour D
    Mol Cancer Res; 2012 Jun; 10(6):821-33. PubMed ID: 22452883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway.
    Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD
    Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of mesenchymal bone morphogenetic protein signaling leads to development of reactive stroma and initiation of the gastric neoplastic cascade.
    Roy SAB; Allaire JM; Ouellet C; Maloum-Rami F; Pomerleau V; Lemieux É; Babeu JP; Rousseau J; Paquet M; Garde-Granger P; Boudreau F; Perreault N
    Sci Rep; 2016 Sep; 6():32759. PubMed ID: 27609464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells.
    Echizen K; Horiuchi K; Aoki Y; Yamada Y; Minamoto T; Oshima H; Oshima M
    Oncogene; 2019 May; 38(22):4250-4263. PubMed ID: 30700829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.
    Chau JF; Jia D; Wang Z; Liu Z; Hu Y; Zhang X; Jia H; Lai KP; Leong WF; Au BJ; Mishina Y; Chen YG; Biondi C; Robertson E; Xie D; Liu H; He L; Wang X; Yu Q; Li B
    Nat Commun; 2012 May; 3():836. PubMed ID: 22588298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines.
    Maeda N; Fu W; Ortin A; de las Heras M; Fan H
    J Virol; 2005 Apr; 79(7):4440-50. PubMed ID: 15767444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.
    Feng T; Zheng L; Liu F; Xu X; Mao S; Wang X; Liu J; Lu Y; Zhao W; Yu X; Tang W
    Oncotarget; 2016 Sep; 7(36):58381-58395. PubMed ID: 27517315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway.
    Yokota S; Okabayashi T; Rehli M; Fujii N; Amano K
    Infect Immun; 2010 Jan; 78(1):468-76. PubMed ID: 19858308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR Signaling in X/A-Like Cells Contributes to Lipid Homeostasis in Mice.
    Li Z; Yu R; Yin W; Qin Y; Ma L; Mulholland M; Zhang W
    Hepatology; 2019 Feb; 69(2):860-875. PubMed ID: 30141265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1.
    Liu P; Zhang M; Niu Q; Zhang F; Yang Y; Jiang X
    Braz J Med Biol Res; 2018 Aug; 51(10):e6839. PubMed ID: 30156609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond.
    Fattahi S; Amjadi-Moheb F; Tabaripour R; Ashrafi GH; Akhavan-Niaki H
    Life Sci; 2020 Dec; 262():118513. PubMed ID: 33011222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.
    Byeon SJ; Han N; Choi J; Kim MA; Kim WH
    J Surg Oncol; 2014 Jun; 109(8):812-7. PubMed ID: 24615476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K/mTOR signaling regulates prostatic branching morphogenesis.
    Ghosh S; Lau H; Simons BW; Powell JD; Meyers DJ; De Marzo AM; Berman DM; Lotan TL
    Dev Biol; 2011 Dec; 360(2):329-42. PubMed ID: 22015718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway.
    Zhang X; Wang S; Wang H; Cao J; Huang X; Chen Z; Xu P; Sun G; Xu J; Lv J; Xu Z
    Mol Cancer; 2019 Feb; 18(1):20. PubMed ID: 30717751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
    Gong L; Shu J; Chen X; Pan H; Chen G; Bi Y; Cui D; Li X; Liu D; Wang L; Wang Y; Liu P; Xiong X; Zhao Y
    Cancer Lett; 2021 Oct; 519():263-276. PubMed ID: 34320372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Ras and Mapks in TGFbeta signaling.
    Mulder KM
    Cytokine Growth Factor Rev; 2000; 11(1-2):23-35. PubMed ID: 10708950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway.
    Kim YW; Lee WH; Choi SM; Seo YY; Ahn BO; Kim SH; Kim SG
    J Gastroenterol Hepatol; 2012 Feb; 27(2):397-405. PubMed ID: 21793913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.